Toshihiro Kita

7PUBLICATIONS
18CO-AUTHORS
Innate immunityMedical molecular engineering of nucleic acids and proteinsBiologically active moleculesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 16, 2025
In Vitro and In Vivo Characterization of 40 kDa PEGylated Adrenomedullin in a DSS-Induced Colitis Model.

Kazuo Kitamura, Emiko Akashi, Sayaka Nagata

|Jul 30, 2025
Adrenomedullin Therapy for Moderate-to-Severe COVID-19 Pneumonia: Double-Blind Placebo-Controlled Phase 2a Trial.

Toshihiro Kita, Norio Ohmagari, Sho Saito

|Jul 15, 2022
Adrenomedullin for biologic-resistant Crohn's disease: A randomized, double-blind, placebo-controlled phase 2a clinical trial.

Toshihiro Kita, Shinya Ashizuka, Teruyuki Takeda

|Mar 25, 2022
Adrenomedullin Therapy in Moderate to Severe COVID-19.

Toshihiro Kita, Kazuo Kitamura

|Aug 27, 2021
Adrenomedullin: A Novel Therapeutic for the Treatment of Inflammatory Bowel Disease.

Shinya Ashizuka, Toshihiro Kita, Haruhiko Inatsu

|Nov 03, 2020
Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial.

Toshihiro Kita, Sinya Ashizuka, Naoki Ohmiya

Pageof 2

Frequent Collaborators

2 joint publications

Kazuo Kitamura

1 joint publications

Shinya Ashizuka

1 joint publications

Naoki Ohmiya

1 joint publications

Tadakazu Hisamatsu